265 related articles for article (PubMed ID: 26357462)
1. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
Islam B; Sharma C; Adem A; Aburawi E; Ojha S
Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
[TBL] [Abstract][Full Text] [Related]
2. Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening.
Lin SH; Huang KJ; Weng CF; Shiuan D
Drug Des Devel Ther; 2015; 9():3313-24. PubMed ID: 26170618
[TBL] [Abstract][Full Text] [Related]
3. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
4. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
5. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
[TBL] [Abstract][Full Text] [Related]
6. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.
Istvan ES; Palnitkar M; Buchanan SK; Deisenhofer J
EMBO J; 2000 Mar; 19(5):819-30. PubMed ID: 10698924
[TBL] [Abstract][Full Text] [Related]
8. Molecular Docking, Synthesis And Biological Evaluation Of Ergosteryl-Ferulate As A Hmg-Coa Reductase Inhibitor.
Aziz S; Elfahmi -; Soemardji AA; Sukrasno -
Pak J Pharm Sci; 2020 May; 33(3):997-1003. PubMed ID: 33191223
[TBL] [Abstract][Full Text] [Related]
9. The structure of the catalytic portion of human HMG-CoA reductase.
Istvan ES; Deisenhofer J
Biochim Biophys Acta; 2000 Dec; 1529(1-3):9-18. PubMed ID: 11111074
[TBL] [Abstract][Full Text] [Related]
10. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone.
Pak VV; Koo M; Kim MJ; Yun L; Kwon DY
Bioorg Med Chem; 2008 Feb; 16(3):1309-18. PubMed ID: 17977732
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase.
Cuccioloni M; Mozzicafreddo M; Spina M; Tran CN; Falconi M; Eleuteri AM; Angeletti M
J Lipid Res; 2011 May; 52(5):897-907. PubMed ID: 21357570
[TBL] [Abstract][Full Text] [Related]
12. On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme.
Leopoldini M; Malaj N; Toscano M; Sindona G; Russo N
J Agric Food Chem; 2010 Oct; 58(19):10768-73. PubMed ID: 20843083
[TBL] [Abstract][Full Text] [Related]
13. Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia.
da Silva VB; Taft CA; Silva CH
J Phys Chem A; 2008 Mar; 112(10):2007-11. PubMed ID: 18044855
[TBL] [Abstract][Full Text] [Related]
14. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
[TBL] [Abstract][Full Text] [Related]
15. Explaining statin inhibition effectiveness of HMG-CoA reductase by quantum biochemistry computations.
da Costa RF; Freire VN; Bezerra EM; Cavada BS; Caetano EW; de Lima Filho JL; Albuquerque EL
Phys Chem Chem Phys; 2012 Jan; 14(4):1389-98. PubMed ID: 22159045
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors.
Mendieta A; Jiménez F; Garduño-Siciliano L; Mojica-Villegas A; Rosales-Acosta B; Villa-Tanaca L; Chamorro-Cevallos G; Medina-Franco JL; Meurice N; Gutiérrez RU; Montiel LE; Cruz Mdel C; Tamariz J
Bioorg Med Chem; 2014 Nov; 22(21):5871-82. PubMed ID: 25311563
[TBL] [Abstract][Full Text] [Related]
17. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking of the highly hypolipidemic agent alpha-asarone with the catalytic portion of HMG-CoA reductase.
Medina-Franco JL; López-Vallejo F; Rodríguez-Morales S; Castillo R; Chamorro G; Tamariz J
Bioorg Med Chem Lett; 2005 Feb; 15(4):989-94. PubMed ID: 15686898
[TBL] [Abstract][Full Text] [Related]
19. The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: a proposal as a therapeutic target and as a study model.
Andrade-Pavón D; Sánchez-Sandoval E; Rosales-Acosta B; Ibarra JA; Tamariz J; Hernández-Rodríguez C; Villa-Tanaca L
Rev Iberoam Micol; 2014; 31(1):81-5. PubMed ID: 24270073
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of HMG-CoA Reductase: Current and Future Prospects.
Singh N; Tamariz J; Chamorro G; Medina-Franco JL
Mini Rev Med Chem; 2009 Oct; 9(11):1272-83. PubMed ID: 19929805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
